AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Jun 132013
 

 

Aphios, VivaCell to Develop Cannabinoid-Based Drugs for MS, CNS Disorders
Genetic Engineering News
Aphios and VivaCell have executed research and commercialization agreements to develop these drug candidates through preclinical studies, clinical development, and commercialization in the U.S. and Europe. Researchers at the University of Córdoba and

http://www.genengnews.com/gen-news-highlights/aphios-vivacell-to-develop-cannabinoid-based-drugs-for-ms-cns-disorders/81248471/

 

 

 

 

Share

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: